Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADVFN Regulatory News (AFN)

Share Price Information for ADVFN (AFN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.50
Bid: 10.00
Ask: 11.00
Change: 0.00 (0.00%)
Spread: 1.00 (10.00%)
Open: 10.50
High: 10.50
Low: 10.50
Prev. Close: 10.50
AFN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

30 Dec 2020 12:38

RNS Number : 1668K
ADVFN PLC
30 December 2020
 

For immediate release 

30 December 2020

ADVFN PLC

("ADVFN" or the "Company")

Director / PDMR shareholding

 

The Board of ADVFN PLC announces that the Board has agreed to amend the terms of 1,222,946 options held by certain directors, in aggregate representing 4.76 per cent. of the issued share capital of the Company. The exercise price of the options has been re-set at 14p per new ordinary share (compared to a closing mid-market price of 11.5p on 29 December 2020). Prior to the amendment, the options had exercise prices substantially greater than the prevailing market price.

The table below sets out the amended options:

Director

Original grant date

M Hodges

C Chambers

 J Mullins

M Collom

Pre-amendment exercise price per share

Amended exercise price per share

27.01.04

40,000

60,000

40,000

0

118.75p

14p

27.01.05

40,000

60,000

40,000

0

115p

14p

06.09.06

60,000

60,000

60,000

0

82.5p

14p

21.10.09

31,473

31,473

0

0

76.4p

14p

12.12.14

200,000

200,000

100,000

200,000

79.5p

14p

The re-setting of the option exercise price was reviewed by the independent non-executive director of the Company, Mr Tom Spiller and approved on 29 December 2020. Other than an amendment to the exercise price, the terms of the options remain unaltered. Other than the options granted in 2014 (which lapse on 12 December 2024), the options set out in the table above will lapse unless exercised on or before 31 December 2022. No other options have been issued or amended in the prior 12-month period.

A copy of this announcement is available on the Company's website, at www.advfn.com

For further information please contact:

ADVFN PLC

Clem Chambers CEO

Tel: +44 20 3868 6702

 

 

Beaumont Cornish Limited (Nominated Adviser)

www.beaumontcornish.com

Roland Cornish/Michael Cornish

Tel: +44 (0) 207 628 3396

 

Cassiopeia Ltd (Investor Relations)

Stefania Barbaglio

stefania@cassiopeia-ltd.com

 The following disclosure is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

1. Michael Hodges

2. Clem Chambers

3. Jonathan Mullins

4. Matthew Collom

2

 

Reason for the notification

 

a)

 

Position/

status

 

 

1. Chairman

2. Chief Executive

3. Director

4. Director

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

ADVFN plc

b)

 

LEI

 

21380042SDV1E1ZVIY40

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Options over Ordinary Shares of 0.2p each ("Ordinary Shares")

Identification code

GB00BPT24C10

 

b)

 

Nature of the transaction

Amendment of exercise price of options over Ordinary Shares

c)

 

Price(s) and volume(s)

Director

Price payable on exercise of option

Volume(s)

 

Michael Hodges

£0.14

371,473

Clem Chambers

£0.14

411,473

Jonathan Mullins

£0.14

240,000

Matthew Collom

£0.14

200,000

d)

 

Aggregated information

- Aggregated volume

1,222,946 options over Ordinary Shares

- Price

Price payable on exercise of option - UK£0.14

e)

 

Date of the transaction

 

29 December 2020

f)

 

Place of the transaction

 

Outside a trading venue

 

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHLBLFXBLLFFBK
Date   Source Headline
21st Mar 20249:49 amRNSHalf-year Report
9th Feb 202411:19 amRNSNew ADVFN Italia website is launched
12th Jan 20242:00 pmRNSResult of Meeting
28th Dec 20231:10 pmRNSResult of AGM
21st Dec 20237:00 amRNSFinal Results
5th Dec 20234:00 pmRNSNotice of AGM
16th Nov 20231:30 pmRNSHolding(s) in Company
21st Sep 202312:00 pmRNSADFVN connects audience to Doceo content
15th Aug 20236:05 pmRNSCorporate update
9th Jun 20236:15 pmRNSDirector/PDMR Shareholding
2nd Jun 202312:14 pmRNSTrading and corporate update
16th May 20234:33 pmRNSHolding(s) in Company
5th May 20233:06 pmRNSTotal Voting Rights
4th Apr 20237:00 amRNSIssue of Equity
30th Mar 20232:07 pmRNSHolding(s) in Company
30th Mar 20232:05 pmRNSHolding(s) in Company
23rd Mar 20235:02 pmRNSHolding(s) in Company
23rd Mar 20235:01 pmRNSHolding(s) in Company
23rd Mar 20235:00 pmRNSHolding(s) in Company
23rd Mar 20233:30 pmRNSDirector/PDMR Shareholding
20th Mar 20236:20 pmRNSAdmission update
14th Mar 202312:05 pmRNSFurther equity issue under the Open Offer
6th Mar 20237:00 amRNSHalf-year Report
6th Feb 202311:53 amRNSDirectorate Change
13th Jan 202311:19 amRNSResult of AGM
11th Jan 20231:15 pmRNSHolding(s) in Company
11th Jan 202311:10 amRNSHolding(s) in Company
11th Jan 202311:10 amRNSHolding(s) in Company
11th Jan 202310:49 amRNSHolding(s) in Company
11th Jan 202310:49 amRNSHolding(s) in Company
10th Jan 20237:00 amRNSCorporate update
9th Jan 20235:22 pmRNSTotal voting rights, Director / PDMR shareholding
6th Jan 20232:04 pmRNSFinal Results of Open Offer
6th Jan 20237:00 amRNSResults of Open Offer
20th Dec 20227:00 amRNSOpen Offer timetable and AGM
6th Dec 20227:00 amRNSOpen Offer
6th Dec 20227:00 amRNSFinal Results
28th Nov 20227:00 amRNSCorporate update
15th Sep 202210:45 amRNSAppointment of joint corporate broker
19th Aug 20224:15 pmRNSCorporate update
8th Aug 20227:00 amRNSDirectorate Change
6th Jun 20227:00 amRNSTrading and Corporate Update
29th Apr 20222:05 pmRNSResult of Meeting
28th Apr 20224:41 pmRNSSecond Price Monitoring Extn
28th Apr 20224:35 pmRNSPrice Monitoring Extension
28th Apr 20222:01 pmRNSHolding(s) in Company
22nd Apr 20224:00 pmRNSTotal Voting Rights
20th Apr 202211:05 amRNSSecond Price Monitoring Extn
20th Apr 202211:00 amRNSPrice Monitoring Extension
13th Apr 20229:29 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.